Page last updated: 2024-09-05

enzastaurin and Carcinoma

enzastaurin has been researched along with Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amant, F; Bauknecht, T; Darstein, C; Kania, M; Michel, AL; Musib, L; Oskay-Oezcelik, G; Sehouli, J; Vergote, I1
Albert, S; Astorgues-Xerri, L; Benhadji, KA; Bieche, I; Emami, S; Faivre, S; Gespach, C; Hammel, P; Raymond, E; Serova, M; Theou-Anton, N; Vidaud, D; Vidaud, M1

Trials

1 trial(s) available for enzastaurin and Carcinoma

ArticleYear
Carboplatin and paclitaxel in combination with oral enzastaurin in advanced ovarian or primary peritoneal cancer: results from a safety lead-in study.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:9

    Topics: Administration, Oral; Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Disease Progression; Drug Interactions; Female; Humans; Indoles; Middle Aged; Neoadjuvant Therapy; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms

2009

Other Studies

1 other study(ies) available for enzastaurin and Carcinoma

ArticleYear
Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cells.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Dedifferentiation; Colonic Neoplasms; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Epithelial Cells; Gene Expression Regulation, Neoplastic; Genes, ras; HCT116 Cells; HT29 Cells; Humans; Indoles; Mesenchymal Stem Cells; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Tumor Cells, Cultured

2010